Technetium Tc-99m Sulfur Colloid

RADIATION7 trials

Sponsors

Gynecologic Oncology Group, M.D. Anderson Cancer Center, Case Comprehensive Cancer Center, University of Washington, University of Michigan Rogel Cancer Center

Conditions

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaEyelid Sebaceous Gland CarcinomaHepatocellular CarcinomaIntrahepatic CholangiocarcinomaMetastatic Castration-Resistant Prostate CarcinomaOral Cavity Squamous Cell Carcinoma

Phase 1

Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Not yet recruitingNCT07682649

University of Michigan Rogel Cancer CenterMetastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8

Start: 2026-08-01End: 2031-08-01Target: 20Updated: 2026-07-06

Phase 2

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

CompletedNCT00832429

M.D. Anderson Cancer CenterEyelid Sebaceous Gland Carcinoma

Start: 2009-02-25End: 2024-08-27Updated: 2025-07-04

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

CompletedNCT02773238

University of WashingtonStage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7

Start: 2016-05-20End: 2023-12-01Updated: 2024-08-14

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

RecruitingNCT07121595

University of Michigan Rogel Cancer CenterOral Cavity Squamous Cell Carcinoma, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8 +2

Start: 2025-07-17End: 2030-07-01Target: 50Updated: 2025-08-13

Unknown Phase

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

TerminatedNCT00070317

Gynecologic Oncology GroupCervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma +1

Start: 2004-06-30End: 2013-01-31Updated: 2017-11-06

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

CompletedNCT02419807

Case Comprehensive Cancer CenterStage I Breast Cancer, Stage II Breast Cancer

Start: 2015-02-17End: 2019-02-28Updated: 2022-06-30

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

TerminatedNCT02881554

University of WashingtonHepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IVA Liver Cancer +3

Start: 2016-12-21End: 2025-02-09Updated: 2025-10-29

Related Papers

Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.

2026-05-28

GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer

Physics in Medicine and Biology2024-07-092 citations

Independent association of metabolic tumor response on FDG-PET with pulmonary toxicity following risk-adaptive chemoradiation for unresectable non-small cell lung cancer: Inherent radiosensitivity or immune response?

2023-05-25

Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?

2022-09-0116 citations

Multitask Learning Radiomics on Longitudinal Imaging to Predict Survival Outcomes following Risk-Adaptive Chemoradiation for Non-Small Cell Lung Cancer

Cancers2022-02-2635 citations

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.

2021-11-213 citations

Prognostic Value and Peripheral Immunologic Correlates of Early FDG PET Response Imaging in a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable NSCLC.

2021-11-01

Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non–Small Cell Lung Cancer

Clinical Nuclear Medicine2021-06-2517 citations

Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer

Physics in Medicine and Biology2020-08-1913 citations

Abstract 6497: Early assessment of liquid biomarkers to predict pneumonitis after chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC)

Cancer Research2020-08-153 citations

Prognostic role of mid-treatment PET/CT and plasma cytokines in patients undergoing chemoradiation for locally advanced non-small cell lung cancer (LA-NSCLC).

Journal of Clinical Oncology2020-05-20

Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy

British Journal of Radiology2019-07-3118 citations

Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging

Clinical Cancer Research2019-05-2914 citations